Brlek, P.; Škaro, V.; Hrvatin, N.; Bulić, L.; Petrović, A.; Projić, P.; Smolić, M.; Shah, P.; Primorac, D.
Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies. Cancers 2025, 17, 3500.
https://doi.org/10.3390/cancers17213500
AMA Style
Brlek P, Škaro V, Hrvatin N, Bulić L, Petrović A, Projić P, Smolić M, Shah P, Primorac D.
Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies. Cancers. 2025; 17(21):3500.
https://doi.org/10.3390/cancers17213500
Chicago/Turabian Style
Brlek, Petar, Vedrana Škaro, Nenad Hrvatin, Luka Bulić, Ana Petrović, Petar Projić, Martina Smolić, Parth Shah, and Dragan Primorac.
2025. "Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies" Cancers 17, no. 21: 3500.
https://doi.org/10.3390/cancers17213500
APA Style
Brlek, P., Škaro, V., Hrvatin, N., Bulić, L., Petrović, A., Projić, P., Smolić, M., Shah, P., & Primorac, D.
(2025). Advances in Precision Oncology: From Molecular Profiling to Regulatory-Approved Targeted Therapies. Cancers, 17(21), 3500.
https://doi.org/10.3390/cancers17213500